Phrma: Drug List Prices In Ads Would Be Confusing

We want to provide cost information in a comprehensive fashion, writes Stephen J. Ubl, CEO of Pharmaceutical Research and Manufacturers of America.        

Topics:  commentary   
RELATED ARTICLES
BING NEWS:
  • Panel for drug price review expanded
    The Department of Pharmaceuticals (DoP) has broadened the consultation process for framing the new pricing policy for drugs and medical devices, by including several industrial bodies and other ...
    04/24/2024 - 8:45 am | View Link
  • It's time to return the serve on extreme Rx pricing
    Using pooled resources, expertise and a wide range of perspectives, brokers and advisers can create a voice louder than Big Pharma.
    04/22/2024 - 6:00 am | View Link
  • A pharma company hiked the price of its eye drug by a whopping 486%
    At least 945 brand name drugs have had their list prices hiked in 2024 so far, according to the non-profit 46Brooklyn. One of the largest was Harrow’s eye medication Triesence at a 486% increase to ...
    04/10/2024 - 11:20 am | View Link
  • More